BayBio Events
Save up to 12% by flying Virgin America

Building a Biotech Business: The Big Picture & The Nitty Gritty

This track shares the fundamental information you will need to build a successful biotech business in the rapidly evolving life science landscape, factoring in the new normal since the 2008 economic collapse. Panels will explore how even successful, seasoned executives change their game, structuring a company to allow for future flexibility, and whether it is even possible to build a biotech company with a lasting legacy.

Track Sponsors:

AccentureArnold PorterCISDLA PiperKnobbe MartensMcKenna Long & Aldridge LLP

Campbell Alliance Deal Makers Intention Survey

Thursday June 13th from 10:15am-11:30am


Confirmed Panelists:

  • Neil Berkley, Director, Business Development, Cadence Pharmaceuticals
  • Charles Theuer, President & CEO, TRACON Pharmaceuticals
  • Michael D. Step, Senior Vice President, Corporate Development, Santarus, Inc.
  • McDavid Stilwell, Vice President, Corporate Communications & Business Development,  Orexigen

The US Government As A Customer —
What Does That Look Like?

Friday June 14th from 11:45pm-1:00pm


  • Linda L. Schock, Director, Commercial Compliance & Government Programs Compliance Implementation Services (CIS)

Confirmed Panelists:

  • Claudia Martinez, Sr. Manager, Contracts & Pricing at Gilead Sciences, Inc.

Navigating the Technology Transfer Maze

Thursday June 13th from 2:45pm-4:00pm


Confirmed Panelists:

  • Scott Forrest,Vice President of Business Development, The Scripps Research Institute
  • Karin Immergluck, Acting Director, Technology Management, UCSF Office of Innovation, Technology and Alliances
  • Philip Low, Founder, Chairman & CEO, NeuroVigil
  • Teri Melese, Assistant Vice Chancellor for Industry Research Alliances, UCSD

Defining the Next-Generation Biopharma

Thursday June 13th 4:15pm-5:30pm


  • Jeff Elton, Managing Director, Life Sciences, Accenture

Law & Order: The Biotech Edition

Friday June 14th from 10:00am-11:15am


  • Ross Burningham, Partner, DLA Piper

Confirmed Panelists:

Leveling the Playing Field

Friday June 14th from 11:30am-12:45am


Confirmed Panelists:

  • Wendy S. Johnson, President and Chief Executive Officer, Aires Pharmaceuticals, Inc.
  • Mark Schwartz, Executive Vice President & Chief Operating Officer, Galena Biopharma, Inc.
  • Randy Woods, CEO, Sophiris Bio

Keeping Your Options Open

Friday June 14th from 1:45pm-3:00pm


Confirmed Panelists:

Networking OpportunitiesExhibit Hall

Business Partnering

More Information

Register Here

Event Sponsors

Platinum Level


Gold Level

Campbell Alliance CMTC Deloitte  Johnson & Johnson Innovation

Silver Level

BioMed Realty Elsevier  Health Advances, LLC  OUM & Co. PPD Sanofi UBIFRANCE

Bronze Level

Accenture  Althea  Arnold & Porter LLP  ASX Group (ASX)  CIS DLA Piper  Fisher Scientific Foley & Lardner  GoIndustry DoveBid Knobbe Martens  McKenna Long & Aldridge LLP

Follow BayBio on Twitter Follow BayBio on Facebook Join BayBio on LinkedIn